UNSPSC 51461515: Coccus cacti

This classification denotes a natural product which US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifiers LZB7TFX1LT and TZ8Z31B35M, and which the Integrated Taxonomic Information System classifies under Taxonomic Serial Number 200985 as a member of Kingdom Animalia, Phylum Arthropoda, Subphylum Hexapoda, Class Insecta, Subclass Pterygota, Infraclass Neoptera, Order Hemiptera, Suborder Sternorrhyncha, Superfamily Coccoidea, Family Dactylopiidae (cochineal insects), Genus Dactylopius, more commonly known as COCHINEAL or as here, COCCUS CACTI.

European Medicines Agency schedules coccus cacti in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Indices SUB34748, SUB51162, and SUB55045. SMILES: O1C(C(O)C(O)C(O)C1CO)C1C(O)C2C(C(O)C1O)C(=O)C1C(C2=O)C(C(C(O)C1)C(=O)O)C.

UNSPSC 51461515 Coccus cacti (Commodity) encompasses generic multi-source pharmaceuticals and over-the-counter products that state and local government health systems, facilities, and cooperative purchasing alliances source through authorized wholesale distributors. State and local buyers under this code include health departments, hospital systems, long-term care facilities, and multistate cooperative purchasing organizations that aggregate demand across member agencies. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents a primary issuing body for this class of procurement, coordinating purchases across participating state and local facilities in multiple jurisdictions including Oregon. Vendors must maintain relationships with authorized wholesalers, comply with current Good Manufacturing Practices and Drug Supply Chain Security Act requirements, and provide comprehensive pricing data indexed to National Drug Codes with flexibility in pricing structures (flat price, net price formats at NF30/NF60/NF90, or WAC-minus). Insurance requirements include $5,000,000 commercial general liability per occurrence, $2,000,000 network security and privacy liability, and $2,000,000 professional liability.

MMCAP issued a Request for Proposal (RFP S1070000015802) on January 20, 2026, for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, and a question cutoff of February 18, 2026. Awards are effective July 1, 2026, with contract terms of two years for new vendors and alignment with incumbent expiration dates through June 30, 2028. Evaluation weighting prioritizes price competitiveness at 75 percent, with fixed pricing (10 percent), administrative format compliance (5 percent), EDI capability (5 percent), and agreement to a 3 percent administrative fee (5 percent). Vendors must maintain relationships with at least two of three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and all products must be available in the marketplace by May 15, 2026. MMCAP reserves multi-award discretion based on therapeutic considerations, product availability, patient safety, and member-specific needs, with performance penalties ranging from $200 to $1,500 per violation.